Invesco
JANX icon

Invesco’s Janux Therapeutics JANX Stock Holding History

Invesco’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$652K Buy
46,923
+18,601
+66% +$255K ﹤0.01% 3045
2025
Q4 		$391K Buy
28,322
+3,853
+16% +$90.6K ﹤0.01% 3289
2025
Q3 		$598K Buy
24,469
+6,170
+34% +$150K ﹤0.01% 3163
2025
Q2 		$423K Sell
18,299
-239,809
-93% -$6.32M ﹤0.01% 3232
2025
Q1 		$6.97M Sell
258,108
-26,554
-9% -$1M ﹤0.01% 1991
2024
Q4 		$15.2M Buy
284,662
+274,724
+2,764% +$14.5M ﹤0.01% 1625
2024
Q3 		$451K Buy
9,938
+285
+3% +$12.4K ﹤0.01% 3276
2024
Q2 		$404K Buy
9,653
+1,846
+24% +$86.7K ﹤0.01% 3361
2024
Q1 		$294K Buy
+7,807
New +$170K ﹤0.01% 3526

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.3B AUM 33.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return